Hydroxychloroquine (HCQ) is a lysosomotropic amine with cytotoxic properties. Here, we show that HCQ induces signs of lysosomal membrane permeabilization (LMP), such as the decrease in the lysosomal pH gradient and the release of cathepsin B from the lysosomal lumen, followed by signs of apoptosis including caspase activation, phosphatidylserine exposure, and chromatin condensation with DNA loss. HCQ also induces mitochondrial membrane permeabilization (MMP), as indicated by the insertion of Bax into mitochondrial membranes, the conformational activation of Bax within mitochondria, the release of cytochrome c from mitochondria, and the loss of the mitochondrial transmembrane potential. To determine the molecular order among these events, we introduced inhibitors of LMP (bafilomycin A 1 ), MMP (Bcl-X L , wild-type Bcl-2, mitochondrion-targeted Bcl-2, or viral mitochondrial inhibitor of apoptosis from cytomegalovirus), and caspases (Z-VAD.fmk) into the system. Our data indicate that caspase-independent MMP is rate-limiting for LMP-mediated caspase activation. Mouse embryonic fibroblasts lacking the expression of both Bax and Bak are resistant against hydroxychloroquine-induced apoptosis. Such Bax À/À Bak À/À cells manifest normal LMP, yet fail to undergo MMP and subsequent cell death. The data reported herein indicate that LMP does not suffice to trigger caspase activation and that Bax/Bak-dependent MMP is a critical step of LMP-induced cell death.
Introduction
Apoptosis can be induced by stresses acting on specific organelles including nuclei, mitochondria, the endoplasmic reticulum, or lysosomes. In spite of the heterogeneity of potential cell death inducers, apoptosis is characterized by common morphological and biochemical alterations. This suggests the existence of interorganellar crosstalk . It is an open conundrum, however, whether apoptotic cell death involves an obligate final pathway. Caspases have been suggested to be universal apoptotic executioners (Nicholson and Thornberry, 1997) , but recent data describing caspase-independent death and noncaspase death effectors argue against this possibility (Mathiasen and Jaattela, 2002; Ravagnan et al., 2002) . Alternatively, it has been proposed that mitochondrial membrane permeabilization (MMP) might constitute a common phenomenon that would mark the point of integration as well as the point-of-non-return of the lethal signal transducing cascade (Green and Reed, 1998; Kroemer and Reed, 2000; Debatin et al., 2002) . In favor of this hypothesis, it appears that overexpression of Bcl-2-like proteins (which inhibit MMP) or knockout of the proapoptotic genes Bax and Bak (whose products induce MMP) confers a broad cytoprotection including against nuclear DNA damage and ER stress (Zamzami et al., 1998; Vogelstein et al., 2000; Ferri and Kroemer, 2001; Wei et al., 2001; Boya et al., 2002; Reed, 2002; Zamzami and Kroemer, 2003) . However, the importance of mitochondria for the regulation of apoptosis is a matter of controversy, and some investigators suggest that they play no central role in cell death control (Lassus et al., 2002; Marsden et al., 2002) .
One of the organelles that participates in the control of caspase-independent cell death is the lysosome, as indicated by several lines of evidence. First, in the course of death, lysosomal proteases from the cathepsin family frequently translocate from the lysosomal lumen to the cytosol (Levy-Strumpf and Kimchi, 1998; Foghsgaard et al., 2001; Roberg, 2001; Mathiasen and Jaattela, 2002; Yuan et al., 2002) . Second, genetic and pharmacological studies demonstrate that either cathepsin B (CB) and D are rate limiting for death induced by interferon-g, tumor necrosis factor-a, p53, or pro-oxidants, at least in some cell types (Levy-Strumpf and Kimchi, 1998; Foghsgaard et al., 2001; Roberg, 2001; Mathiasen and Jaattela, 2002; Yuan et al., 2002) . Third, overexpression of oncogenic Ras, DAP-kinase, and DRP-1 can induce caspase-independent cell death with increased autophagy, indicating that some lethal signal-transducing systems can elicit lysosome-dependent cell death Inbal et al., 2002; Kitanaka et al., 2002) . Fourth, in a model of caspase-independent neuronal cell death, increased macroautophagy, which requires the contribution of lysosomes, causes the self-elimination of atrophic cells (Xue et al., 2001) .
Stimulated by these findings, we decided to address the hitherto unresolved question as to whether a primary damage affecting lysosomes induces cell death through activation of the mitochondrial apoptotic pathway. To address this issue, we took advantage of the lysosomotropic amine hydroxychloroquine, which is clinically used for the treatment of malaria, rheumatoid arthritis, and systemic lupus erythematosus. As do other immunosuppressive drugs, this agent exerts potent cytotoxic effects (Lai et al., 2001) , which in part may explain unwarranted effects on the nervous system and the retina (Zaidi et al., 2001; Marmor et al., 2002) . Here we report that hydroxychloroquine (HCQ) induces cell death apoptosis through a lysosomal mechanism. Our data indicate that Bax/Bak-mediated MMP is a rate limiting step of cell death, primarily triggered at the lysosomal level. Mitochondrial alterations thus determine lysosome-initiated cell death induced by HCQ.
Results and discussion
HCQ triggers selective CB translocation from lysosomes HCQ (which is fluorescent, Figure 1a ) enriches in cytoplasmic organelles as well as nucleoli (Figure 1a ). When cells are treated with bafilomycin A 1 (Baf A 1 ), a specific inhibitor of the lysosomal proton pump (vacuolar H þ ATPase) (Moriyama and Nelson, 1989) , the cytoplasmic organellar distribution of HCQ is lost. Staining of cells with the acidophilic lysosomal probe LysoTracker Red (LTR) revealed that HCQ caused an increase in lysosomal volume. Concomitantly, HCQ triggered an increase in the frequency of cytoplasmic organelles staining with monodansylcadaverine, a dye that specifically stains autophagic vacuoles (Biederbick et al., 1995; Munafo and Colombo, 2001) (Figure 1b ). These effects were suppressed when cells were pretreated with Baf A 1 . HCQ also caused a progressive decline in the red staining of lysosomes with acridine orange (AO), as determined at the single-cell level (Figure 1c ) or by cytofluorometry (Figure 1d ). Finally, HCQ triggered the release of CB from lysosomes (where it colocalizes normally with the sessile lysosomal marker Lamp-1) to the cytosol and the nucleus. This translocation of CB is HCQ triggers apoptosis and MMP through a lysosomal pathway HCQ treatment resulted in marked cytoplasmic vacuolization and apoptosis with cellular shrinkage and pathognonomic chromatin condensation. Importantly, vacuolization became manifest before marked chromatin condensation and was accompanied by signs of increased macroautophagy. These changes could be detected by electron microscopy (Figure 2a ), as well as by Giemsa staining (Figure 2b ). HCQ also caused phosphatidylserine (PS) exposure on the outer leaflet of the plasma membrane, which can manifest before plasma membrane permeabilization (PMP) (Figure 2c ). Both PS exposure and PMP could be inhibited by pretreating cells with Baf A 1 , indicating that they must be secondary to LMP. HCQ did also trigger signs of MMP. First, HCQ induced a mitochondrial transmembrane potential (DC m ) loss, as detectable with two different DC m -sensitive dyes, namely 3,3 0 -dihexyloxacarbocyanine iodide (DiOC 6 (3)) (which is amenable to cytofluorometric analysis, Figure 3a ) and JC-1 (which is useful for microscopic observation, Figure 3b ). Again, these HCQ effects were fully blocked by BafA 1 (Figure 3a ), indicating that HCQ did indeed trigger apoptosis by acting on lysosomes rather than on other organelles such as mitochondria or nuclei. HCQ also provoked the mitochondrial release of cytochrome c and the concomitant activation of caspase-3 (Figure 3c ), as detected with an antibody specific for the large subunit of caspase-3 (Casp-3a). To determine the temporal order between LMP and MMP, HCQ-treated cells were double-stained for the simultaneous detection of CB and cytochrome c. While a fraction of cells manifested a diffuse CB staining with a punctate cytochrome c distribution (indicating LMP without MMP), we found no cells in which cytochrome c would be diffuse, yet CB was retained in lysosomes ( Figure 3d ). Thus, LMP occurs clearly upstream of MMP in this model.
HCQ-induced apoptosis involves the activation of caspases and of proapoptotic Bcl-2 family members
To determine the relative contribution of cathepsines and caspases to HCQ-induced apoptosis, cells were pretreated with a panel of protease inhibitors. While all tested cathepsin inhibitors failed to affect the death of HCQ-treated cells, we found that the pan-caspase inhibitor N-benzyloxycarbonyl-Phe-Ala-fluoromethylketone (Z-VAD.fmk) significantly reduced the HCQinduced killing (Figure 4a , b). Z-VAD.fmk fully blocked Casp-3 activation ( Figure 4c ) and prevented the HCQ-induced chromatin condensation and DNA loss ( Figure 4d ). In many paradigms of apoptosis induction, Bax translocates to mitochondria, where it inserts into the outer membrane, exposes its N-terminus, oligomerizes and coalesces into large complexes (Goping et al., 1998; Gross et al., 1998; Griffiths et al., 1999) . HCQ was found to induce the 'apoptotic conformation' of Bax (Figure 5a ), as detectable with specific monoclonal antibody recognizing the exposed N-terminus of activated Bax. These alterations were not affected by Z-VAD.fmk (Figure 5b ), yet were inhibited by Baf optionally pretreated with Baf A 1 were subjected to simultaneous staining with Annexin V-FITC and PI, followed by cytofluorometric analysis A 1 (not shown). Moreover, Z-VAD.fmk failed to inhibit the release of both CB and cytochrome c from lysosomes and mitochondria, respectively. These data indicate that caspases operate downstream of LMP and MMP.
MMP is a rate limiting step of LMP-triggered apoptosis
To investigate the importance of MMP for apoptosis induction by HCQ, we took advantage of a series of cell lines in which MMP is blocked by genetic vMIA (viral mitochondrial inhibitor of apoptosis) (from cytomegalovirus) (Goldmacher et al., 1999; Vieira et al., 2001) were partially protected against the HCQ-driven MMP and PMP (Figure 6a ). These findings could be substantiated in different cell lines, including BJAB Bcell leukemia and Jurkat T-lymphoma cells, in which Bcl-2 or vMIA inhibited HCQ-induced killing ( Figure  6b , c). Rat-1 fibrosarcoid cells were also partially protected against HCQ, when engineered to overexpress wild-type Bcl-2. When Bcl-2 was specifically targeted to the endoplasmic reticulum (Bcl-Cb5) (Zhu et al., 1996) , it lost its cytoprotective action vis-a`-vis of HCQ. In contrast, Bcl-2 targeted to mitochondria (Bcl-ActA) inhibited HCQ-mediated killing as efficiently as wildtype Bcl-2 (Figure 6c ). Mouse embryonic fibroblasts (MEF) lacking both Bax and Bak (Wei et al., 2001) were completely resistant against HCQ-induced MMP and PMP (Figure 7a ). Partial inhibition against HCQ killing was also obtained by knockout of Bax alone (Figure 7b ). Figure 3d ), a diffuse cytochrome c staining (determined as in Figure 3c ) and activation of Bax (determined as in Figure 5b ). Results are means of three determinations7s.d.
Lysosomes and mitochondria in apoptosis P Boya et al organelles. In Bax À/À Bak À/À MEF, HCQ did induce the redistribution of CB (Figure 7c ), yet failed to induce the mitochondrial release of cytochrome c (not shown), loss of the DC m and cell death (Figure 6a ). Altogether these data indicate that Bax/Bak-mediated MMP, downstream of LMP, is an obligate step of LMP-triggered apoptosis.
Concluding remarks
Based on the data accumulating in this paper, HCQ induces a precise sequence of subcellular alterations culminating into cell death. This sequence involves (i) lysosomal accumulation resulting into selective LMP with release of lysosomal enzymes such as CB, (ii) activation of Bax with consequent MMP, and (iii) caspase activation and apoptosis. This hierarchy (LMP-MMP-caspase activation) is demonstrated by the facts that (i) Baf A 1 , an inhibitor of the lysosomal accumulation of HCQ (Figure 1a) , prevents all signs of HCQ-induced LMP (Figure 1b, e) , MMP (Figure 3a) , and apoptosis ( Figure 2c) ; that (ii) inhibitors of MMP such as Bcl-2, Bcl-XL, vMIA or the absence of Bax and/ or Bak largely prevent HCQ-induced MMP and apoptosis but not LMP (Figures 6 and 7) , and (iii) that Z-VAD.fmk stops caspase activation and retards cell death, yet has no effect on HCQ-induced LMP and a minor inhibitory effect on HCQ-induced MMP (Figures  4 and 5) . These data thus place MMP as an obligate link between LMP, on the one hand, and caspase activation, on the other hand. Although it is possible that long-term LMP might cause cell death in the absence of MMP and caspase activation, our data clearly indicate that inhibition of MMP and caspases retards cell death for a considerable period, that is several days (Figure 4d ). Rat-1 cells engineered to express wild-type Bcl-2 or Bcl-2 specifically targeted to mitochondria (Bcl-2 ActA) or to the ER (Bcl2 Cb5) were exposed to HCQ (60 mg/ml, 16 h) and the percentage of cells with a low DC m (DiOC 6 (3) low ) or a permeable plasma membrane (PI þ ) was determined as in (a) Results are representative of a minimum of three independent determinations
The data presented here are incompatible with the previous studies performed in cell-free systems, which suggested a direct link between lysosomal activation/ permeabilization and caspase activation. Thus, it has been suggested that CB would directly activate caspase-11 (Schotte et al., 1998) and/or trigger apoptotic chromatin condensation and nuclear DNA loss ( Vancompernolle et al., 1998) . However, the presence of CB in the nucleus is not sufficient to induce apoptosis, as shown by the fact that Bax À/À Bak À/À cells can release cathepsin from lysosomes, yet manifest a normal chromatin structure and fail to translocate cytochrome c (Figure 7) .
It has been suggested that cathepsin L released from lysosomes might proteolytically activate Bid, which in turn would act on mitochondria to cause MMP and subsequent caspase activation Stoka et al., 2001 ). However, Bid À/À cells were found to manifest MMP at least as efficiently as control cells (not shown), indicating that Bid is not the major factor linking LMP to MMP. In contrast, either Bax or Bak are rate limiting for the LMP-induced MMP, as demonstrated by the fact that the knockout of either Bax or Bak (but in particular the knockout of both Bax and Bak) greatly reduces HCQ-induced MMP and subsequent cell death (Figure 7 ). Bax is activated in an orthodox fashion subsequent to HCQ-induced LMP, as indicated by the finding that Bax manifests a mitochondrial staining pattern while exposing its N-terminus (Figure 5a, b) . This conformational change of Bax is commonly observed in different models of apoptosis induction (Goping et al., 1998; Gross et al., 1998; Griffiths et al., 1999; Nechushtan et al., 2001) . However, how Bax is activated in response to LMP remains an ongoing conundrum. Thus, a variety of cathepsin-specific The data presented in this paper reinforce the general idea that MMP is rate limiting for cell death induction (Boya et al., 2003) , even when apoptosis has initially been triggered by permeabilizing the 'suicide bags', as lysosomes have been initially nick-named (De Duve and Wattiaux, 1966; Lockshin and Zakeri, 2001 ). This finding has far reaching implications for our current understanding of 'type I' (apoptotic) versus 'type II' (autophagic/lysosomal) cell death. Indeed HCQ-induced cell death is preceded by signs of 'type II cell death', namely increased autophagy (Figure 1b) , organellar sequestration in autophagosomes ( Figure 2a ) and cytoplasmic vacuolization (Figure 2a, b) , followed by later signs of 'type I cell death', as indicated by chromatin condensation, caspase activation, DNA loss and shrinkage (Figures 1 and 2) . Future studies will confirm whether cellular demise initiated as 'type II cell death' always requires a mitochondrial contribution or whether some physiological stimuli, lysosomal activators or cell types may bypass the stringent requirement for mitochondria. Importantly, it appears that MMP-inhibitory, Bcl-2-like molecules have an unsuspectedly wide range of cytoprotective action, thereby further emphasizing why these oncoproteins are that important for cancer development.
Materials and Methods

Cell lines and culture conditions
HeLa and BJAB cells transfected with pcDNA3.1 control vector (Neo), human Bcl-2 or the cytomegalovirus UL37 exon 1 gene coding for vMIA (were a gift by Dr V Goldmacher) (Goldmacher et al., 1999) . Jurkat cells transfected with Neo or Bcl-2 were kindly provided by Nicole Israel (Aillet et al., 1998) . Rat-1/Myc fibroblasts (kindly provided by Dr David Andrews) were stably transfected with pRc/CMV-based plasmids (Neo) and engineered to express human wild-type Bcl-2, ER-targeted Bcl-2-Cb5, or mitochondrion-targeted Bcl-2 ActA (Zhu et al., 1996; Annis et al., 2001) . These cells were cultured in DMEM medium supplemented with 10% FCS, 1 mm pyruvate, 10 mm HEPES and 100 U/ml penicillin/ streptomycin at 371C in 5% CO 2 . SV40-transformed MEF whose genotype was either wild-type (WT), Bax (Wei et al., 2001) were a gift by Dr Stanley Korsmeyer. MEF were cultured in IMDM (Life Technologies) with 20% FCS, 1 Â NEAA (Sigma), and 100 U/ ml pencillin/streptomycin. Cells were cultured in the presence of the indicated dose of HCQ (Sanofi-Synthe´labo, diluted from a stock solution of 30 mg/ml). Baf A 1 (Baf A 1 , Sigma, 0.1 mm), N-benzyloxycarbonyl-Phe-Ala-fluoromethylketone (z-FA-fmk, 100 mm; Bachem), N-benzyloxycarbonyl-ValAla-Asp-fluoromethylketone (z-VAD-fmk; 100 mm; Bachem), N-benzyloxycarbonyl-Phe-Phe-fluoromethylketone (z-FF-fmk; 100 mm; Enzyme System Products), CA-074-Me (10 mm, Peptides International), or pepstatin A (100 mm, Sigma) were added 1 h before the addition of HCQ.
Quantification of apoptosis-associated changes by cytofluorometry
To determine the intracellular localization of HCQ, cells cultured on coverslips were treated with 10 mg/ml of HCQ for 15 min and subjected to fluorescence microscopy. To label lysosomes, cells were stained with either 0.5 mm LysoTracker Red (Molecular Probes) or 5 mm AO (Sigma) for 15-30 min at 371C and then analysed by fluorescence microscopy or flow cytometry (Zhao et al., 2001 ) using a FACS s Vantage (Becton Dickinson). DiOC 6 (3) (40 nm) was employed for cytofluorometric DC m quantification, propidium iodide (PI, 1 mg/ml) for determination of cell viability, and Annexin V labeled with fluorescein isothiocyanate (FITC) (Bender Medsystems) for the assessment of PS exposure (Zamzami et al., 1995; Castedo et al., 1996 Castedo et al., , 2002 . Cells were trypsinized and labeled with the fluorochromes at 371C followed by cytofluorometric analysis. Quantification of DNA content was performed on ethanolfixed stained with 4 0 ,6-diamidino-2-phenylindole, dihydrochloride (DAPI, 2.5 mg/ml, Molecular Probes) for 30 min at 371C. For the assessment of the DC m in situ, cells grown on cover slips were incubated with 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolylcarbocyanine iodide (JC-1, 3 mm, Molecular Probes) and Hoechst 33342 (2 mm, Sigma) (Castedo et al., 2001; Ferri et al., 2000) .
Immunofluorescence, electron microscopy, Giemsa staining, and immunochemistry For immunofluorescence staining, cells were fixed with paraformaldehyde (4% w : v) and picric acid (0.19% v : v) (Daugas et al., 2000) and stained for the detection of cytochrome c (mAb 6H2.B4 from Pharmingen), activated Bax (mAb 6A7, Pharmingen), CB (Calbiochem), a polyclonal rabbit antibody recognizing activated caspase-3 (Casp-3a, Cell Signaling Technology), or Lamp1 (mAb from BD Transduction laboratories), all detected by a goat anti-mouse or goat anti-rabbit IgG conjugated with Alexa s fluorochromes (Molecular Probes). Bars represent 10 mm. For electron microscopy, cells were fixed for 1 h at 41C in 2.5% glutaraldehyde in PBS (pH 7.4), washed and fixed again in 2% osmium tetroxide, before embedding in Epon. Electron microscopy was performed with an Leo 902 electron microscope, at 80 kv, on ultrathin sections (80 nm) stained with uranyl acetate and lead citrate. Bars represent 5 mm. Giemsa stainings were performed using a kit from Sigma. To confirm caspase-3 activation, cells were lysed for 15 min in 50 mm HEPES, 150 mm NaCl, 5 mm EDTA, 0.1% NP-40, supplemented with protease inhibitor cocktail (Roche), 1 mm DTT and 1 mm PMSF, and then centrifuged at 13 000 g for 10 min to remove cell debris. Protein (40 mg) was loaded on a 15% SDS-PAGE. Anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Chemicon) was used to control equal loading, and an antiserum recognizing Casp3a (Cell Signaling Technology) was used for the detection of caspase activation.
Abbreviations AO, acridine orange; Baf A 1 , bafilomycin A 1 ; Casp-3a, activated caspase-3; CB, cathepsin B; DC m , mitochondrial transmembrane potential; DAPI, 4 0 ,6-diamidino-2-phenylindoledihydrochloride; DiOC 6 (3), 3,3 0 -dihexyloxacarbocyanine iodide, DN,dominant negative; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; JC-1,5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3, 3 0 -tetraethylbenzimidazolylcarbocyanine iodide; HCQ, hydroxychloroquine; LMP, lysosomal membrane permeabilization; MMP, mitochondrial membrane permeabilization; PMP, plasma membrane permeabilization; PS, phosphatidylserine; z-FA-fmk, N-benzyloxycarbonyl-Phe-Ala-fluoromethylketone; Z-VAD.fmk, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone; vMIA, viral mitochondrial inhibitor of apoptosis.
